Abstract:
Composition comprising one or more peptide and one or more B-vitamins. Preferably the ACE inhibiting peptides are chosen from tripeptides and/or dipeptides, more preferably from VPP, IPP, LPP, VY, VF, IW, HLPLP, VAP, AW, LW, HLP, IY, FY, PPL, YP, TPP, and MPP.
Abstract:
Frozen confections having a combination of ingredients which permit the formulator to continue to provide outstanding organoleptic properties while at the same time reducing the caloric impact for those consumers who desire to limit their caloric intake. In a first aspect, the invention relates to a frozen confection which comprises less than 5 wt.% triglyceride fat, polydextrose and tricalcium phosphate. In another aspect, the product includes both polydextrose and cream, optionally in combination with tricalcium phosphate and/or karaya gum to produce a low fat frozen confection with good organoleptic properties. In a further aspect, the invention comprises a frozen confection comprising: less than 5 wt.% triglyceride fat, polydextrose, and a karaya gum. The products of the invention combine good organoleptic properties with a substantially reduced fat level compared to regular fat and, especially premium and super-premium ice creams. Preferably, the confection employs a level of triglyceride fat which is less than 1 wt.%, more preferably less than 0.5 wt.%.
Abstract:
The invention relates to uses of hydrocarbon / lipid complexes with carotenoids for improvement properties of hydrocarbon-based products as well as related methods and uses.
Abstract:
Compositions comprising epigallocatechin gallate and 4-(4-hydroxyphenyl)-2-butanone may be used for the treatment or prevention of obesity or conditions associated with obesity such as non-insulin-dependent diabetes mellitus (NIDDM, type II) and syndrome X. The compositions may find use in the nutritional field as a supplement to food and beverages, as well as as a pharmaceutical formulation.
Abstract:
The invention relates to nutraceutical compositions comprising at least two ingredients from the groups of EGCG, pantethine or a metabolite thereof, phytanic acid, lipoic acid, policosanol and coenzyme Q-10 and their use in the treatment or prevention of diabetes or obesity.
Abstract:
Concerning foods, drinks, cosmetics, drugs, feeds and so on, it is intended to prevent the skin from aging and maintaining and improving health. More specifically speaking, the technical feature resides in preparing a TGF−&bgr; production/collagen production enhancer containing as the active ingredients royal jelly and L−ascorbic acid or a TGF−&bgr; production enhancer containing as the active ingredient royal jelly alone, orally or percutaneously administering the former to fibroblasts or the latter to keratinocytes, thus enhancing the production of TGF−&bgr; in fibroblasts/keratinocytes of the subject animal to thereby enhance the production of collagen in fibroblasts or promote the proliferation of keratinocytes. Thus, the production of collagen, which is a major constituent of derm, tissues and organs, can be enhanced or fibroblasts occurring in derm constituting the skin or keratinocytes occurring in epiderm can be activated.
Abstract:
Frozen confections having a combination of ingredients which permit the formulator to continue to provide outstanding organoleptic properties while at the same time reducing the caloric impact for those consumers who desire to limit their caloric intake. In a first aspect, the invention relates to a frozen confection which comprises less than 5 wt.% triglyceride fat, polydextrose and tricalcium phosphate. In another aspect, the product includes both polydextrose and cream, optionally in combination with tricalcium phosphate and/or karaya gum to produce a low fat frozen confection with good organoleptic properties. In a further aspect, the invention comprises a frozen confection comprising: less than 5 wt.% triglyceride fat, polydextrose, and a karaya gum. The products of the invention combine good organoleptic properties with a substantially reduced fat level compared to regular fat and, especially premium and super-premium ice creams. Preferably, the confection employs a level of triglyceride fat which is less than 1 wt.%, more preferably less than 0.5 wt.%.
Abstract:
Disclosed is a composition and method for reducing cravings for a craved substance, particularly foods, with preparations containing 5-hydroxytryptophan (5-HTP). The 5-HTP is added to the same or similar substance that is actually craved to reduce the craving for the craved substance while further satisfying the craving by consumption of a reduced amount of the craved substance.
Abstract:
A fenugreek seed material having reduced odor and taste is provided. Products derived from the fenugreek seed material are also provided. The fenugreek seed material of the invention has reduced odor and taste compared to native fenugreek but maintains all of the biological activity of native fenugreek. Methods for reducing the intestinal absorption of a caloric and/or cholesterol compound from a caloric and/or cholesterol containing comestible in a human and for removing cholesterol from a cholesterol containing comestible are also provided.